1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ALNYLAM PHARMACEUTICALS INC
Alnylam Pharmaceuticals Inc XNAS: ALNY

Alnylam Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the m...

Read More
342.95 12.40 (3.75%)
New 52W High today
450.9K
XNAS Volume

XNAS 30 Jul, 2025 10:49 AM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Alnylam Pharmaceuticals Inc is on 01 Aug 2025 for the purpose of Alnylam Pharmaceuticals Inc Second Quarter Earnings Results for 2025 See details
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
5.0 / 100
Momentum Score
Technically Neutral
56.1 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
341
1Yr Price target downside is -1%
31 analysts

24

S

7

W

5

O

0

T

SWOT Analysis

Alnylam Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..